DVA vs LH
Davita Inc. and Labcorp Holdings Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | DVA | LH |
|---|---|---|
| Revenue | $13.6B | $14.0B |
| Net income | $746.8M | $876.5M |
| Gross margin | — | 28.8% |
| Net margin | 5.5% | 6.3% |
| Return on equity | 159.1% | 10.5% |
| Diluted EPS | $9.84 | $10.46 |
| Dividend / share | — | $2.88 |
| Payout ratio | 0.0% | 27.5% |
| Free cash flow | $1.3B | $1.2B |
| Equity | $-651.1M | $8.6B |
| Net debt / equity | 69.19× | 0.59× |
| Current ratio | 1.29× | 1.42× |
| Revenue CAGR 5y | 3.4% | −0.0% |
| Profit CAGR 5y | −0.7% | −10.8% |
DVA and LH book revenue within 15% of each other, and LH keeps more of each dollar of revenue as profit (6.3% against 5.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | DVA | LH |
|---|---|---|
| FY2025 | $13.6B | $14.0B |
| FY2024 | $12.8B | $13.0B |
| FY2023 | $12.1B | $12.2B |
| FY2022 | $11.6B | $11.9B |
| FY2021 | $11.6B | $13.1B |
| FY2020 | $11.6B | $14.0B |
| FY2019 | $11.4B | $11.6B |
| FY2018 | $10.7B | $11.3B |
| FY2017 | $10.1B | $10.3B |
| FY2016 | $9.7B | $9.6B |
Net income by year
Bottom line
| Fiscal year | DVA | LH |
|---|---|---|
| FY2025 | $746.8M | $876.5M |
| FY2024 | $936.3M | $746.0M |
| FY2023 | $691.5M | $418.0M |
| FY2022 | $560.4M | $1.3B |
| FY2021 | $978.5M | $2.4B |
| FY2020 | $773.6M | $1.6B |
| FY2019 | $811.0M | $823.8M |
| FY2018 | $159.4M | $883.7M |
| FY2017 | $663.6M | $1.2B |
| FY2016 | $879.9M | $711.8M |
Advertisement
AdSense · Rectangle 336×280